Profile
Rosh Chandraratna is the founder of Io Therapeutics, Inc. Former positions include Director & Chief Scientific Officer at NuRx Pharmaceuticals, Inc. from 2007 to 2009, Vice President-Retinoid Research at Allergan, Inc. in 2004, Senior Vice President-Research & Development at Vitae Pharmaceuticals LLC from 2004 to 2006, and Senior Vice President-Research & Development at Acucela, Inc. from 2006 to 2007.
Former positions of Rosh Chandraratna
| Companies | Position | End |
|---|---|---|
| NURX PHARMACEUTICALS INC | Chief Tech/Sci/R&D Officer | 03/10/2009 |
| ACUCELA INC | Chief Tech/Sci/R&D Officer | 01/05/2007 |
| VITAE PHARMACEUTICALS INC | Chief Tech/Sci/R&D Officer | 01/09/2006 |
| ALLERGAN, INC. | Chief Tech/Sci/R&D Officer | 01/05/2004 |
Io Therapeutics, Inc.
Io Therapeutics, Inc. BiotechnologyHealth Technology Develops retinoid and rexinoid molecule drugs for treatment of cancer | Founder | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Allergan, Inc.
Allergan, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Io Therapeutics, Inc.
Io Therapeutics, Inc. BiotechnologyHealth Technology Develops retinoid and rexinoid molecule drugs for treatment of cancer | Health Technology |
Vitae Pharmaceuticals LLC
Vitae Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops small molecule compounds | Health Technology |
Acucela, Inc.
Acucela, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company | Health Technology |
NuRx Pharmaceuticals, Inc.
NuRx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
- Stock Market
- Insiders
- Rosh Chandraratna
















